Trial Testing Ftorafur (UFT) Associated With Neoadjuvant Radiotherapy Versus Radiotherapy Alone in Rectal Adenocarcinoma (UFT RT Phase 3)

This study has been terminated.
(Terminated after interim analysis)
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
ICO Paul Papin
ClinicalTrials.gov Identifier:
NCT00207831
First received: September 13, 2005
Last updated: July 20, 2010
Last verified: July 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: February 2008
  Primary Completion Date: June 2007 (Final data collection date for primary outcome measure)